UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial

JACC. Cardiovascular interventions, 2009-10, Vol.2 (10), p.909

2009

Volltextzugriff (PDF)

A (-5, -7) ProPSA based artificial neural network to detect prostate cancer

European urology, 2006-11, Vol.50 (5), p.1014-1020

2006

Volltextzugriff (PDF)

Acceleration of skeletal maturation in Central Europe over the last two decades: insights from two cohorts of healthy children

Pediatric radiology, 2024-09, Vol.54 (10), p.1686-1691

2024

Volltextzugriff (PDF)

Applicability and robustness of an artificial intelligence-based assessment for Greulich and Pyle bone age in a German cohort

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2024-06, Vol.196 (6), p.600-606

2024

Volltextzugriff (PDF)

Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer

European urology, 2012-04, Vol.61 (4), p.851-854

2012

Volltextzugriff (PDF)

A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center

World journal of urology, 2014-08, Vol.32 (4), p.891-897

2014

Volltextzugriff (PDF)

Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening

Urologia internationalis, 2015-01, Vol.94 (3), p.330-336

2015

Volltextzugriff (PDF)

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

The New England journal of medicine, 2008-05, Vol.358 (21), p.2205-2217

2008

Volltextzugriff (PDF)

Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

JNCI : Journal of the National Cancer Institute, 2017-04, Vol.109 (4)

2017

Volltextzugriff (PDF)

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

The Lancet (British edition), 2017-10, Vol.390 (10104), p.1747-1757

2017

Volltextzugriff (PDF)

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

Urology (Ridgewood, N.J.), 2000-04, Vol.55 (4), p.481-485

2000

Volltextzugriff (PDF)

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors

Brain research bulletin, 2024-06, Vol.212, p.110955-110955, Article 110955

2024

Volltextzugriff (PDF)

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Urologia internationalis, 2022-01, Vol.106 (1), p.83-89

2022

Volltextzugriff (PDF)

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

World journal of urology, 2015-08, Vol.33 (8), p.1189-1196

2015

Volltextzugriff (PDF)

A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations

The Journal of urology, 2003-10, Vol.170 (4), p.1175-1179

2003

Volltextzugriff (PDF)

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

The Journal of urology, 2001-09, Vol.166 (3), p.851-855

2001

Volltextzugriff (PDF)

Prostate-Cancer Mortality at 11 Years of Follow-up

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

Urology (Ridgewood, N.J.), 1998-09, Vol.52 (3), p.360-365

1998

Volltextzugriff (PDF)

Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

Urology (Ridgewood, N.J.), 2012-09, Vol.80 (3), p.564-569

2012

Volltextzugriff (PDF)

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

European urology, 2015-10, Vol.68 (4), p.591-597

2015

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

European urology, 2012-11, Vol.62 (5), p.745-752

2012

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library (Online service)

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(28)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial

A (-5, -7) ProPSA based artificial neural network to detect prostate cancer

Acceleration of skeletal maturation in Central Europe over the last two decades: insights from two cohorts of healthy children

Applicability and robustness of an artificial intelligence-based assessment for Greulich and Pyle bone age in a German cohort

Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer

A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center

Differences among Men on Active Surveillance for Very Low-Risk Prostate Cancer Detected Through Population-Based versus Opportunistic Prostate-Specific Antigen-Screening

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

A Multicenter Clinical Trial On the Use of Complexed Prostate Specific Antigen in Low Prostate Specific Antigen Concentrations

PROSPECTIVE DETECTION OF CLINICALLY RELEVANT PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN RANGE 1 TO 3 NG./ML. COMBINED WITH FREE-TO-TOTAL RATIO 20% OR LESS: THE AARAU EXPERIENCE

Prostate-Cancer Mortality at 11 Years of Follow-up

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL

Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Screening and Prostate-Cancer Mortality in a Randomized European Study

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Aktive Filter

Suchergebnisse filtern